Advantages of Residential Substance Abuse Treatment In Sacramento Explained By TheRecover.com
Apr 27, 2018 11:14 am UTC| Business
SAN DIEGO, April 27, 2018 -- TheRecover.com is a news and articles website dedicated in providing relative information about drug and alcohol treatment for people struggling with addiction. There are many residential...
Myriad Genetics to Present at Two Upcoming Healthcare Conferences
Apr 27, 2018 11:10 am UTC| Business
SALT LAKE CITY, April 27, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at two...
Super Absorbent Polymers Market to Reach US$ 8,173.1 mn by 2025 – Persistence Market Research
Apr 27, 2018 11:07 am UTC| Business
New York, April 27, 2018 -- The global superabsorbent polymer market is choc-o-bloc with companies both small and large. However, the market features a largely consolidated vendor landscape with top three players...
Apr 27, 2018 11:05 am UTC| Business
SALT LAKE CITY, April 27, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that results from a large prospective process-intervention study that...
Golar LNG Partners LP Cash Distributions
Apr 27, 2018 11:02 am UTC| Business
Golar LNG Partners LP ("the Partnership") (NASDAQ: GMLP) announced today that its board of directors has approved a quarterly cash distribution with respect to the quarter ended March 31, 2018 of $0.5775 per common and...
Advantagene Announces Clinical Trial Collaboration
Apr 27, 2018 11:00 am UTC| Business
AUBURNDALE, Mass., April 27, 2018 -- Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE:BMY) to evaluate the safety, tolerability, and...
uniQure Announces to Present at Multiple Conferences in May
Apr 27, 2018 11:00 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 27, 2018 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that it will be featured in multiple presentations at upcoming medical and...